{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:21:33Z","timestamp":1779358893879,"version":"3.51.4"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1097\/mcg.0b013e3181f18c4e","type":"journal-article","created":{"date-parts":[[2010,9,19]],"date-time":"2010-09-19T18:46:04Z","timestamp":1284921964000},"page":"e66-e71","source":"Crossref","is-referenced-by-count":48,"title":["Varices in Early Histological Stage Primary Biliary Cirrhosis"],"prefix":"10.1097","volume":"45","author":[{"given":"Ahmad H.","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanouil","family":"Sinakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina G.","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta A.","family":"Jorgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Angulo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith D.","family":"Lindor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20-20210305","first-page":"387","article-title":"Primary biliary cirrhosis. chronic non-suppurative destructive cholangitis.","volume":"46","author":"Rubin","year":"1965","journal-title":"Am J Pathol"},{"key":"R3-20-20210305","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM199105303242204","article-title":"A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-UPBC Study Group.","volume":"324","author":"Poupon","year":"1991","journal-title":"NEJM"},{"key":"R4-20-20210305","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/hep.1840190512","article-title":"The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.","volume":"19","author":"Heathcote","year":"1994","journal-title":"Hepatology"},{"key":"R5-20-20210305","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/0016-5085(94)90021-3","article-title":"Ursodeoxycholic acid in the treatment of primary biliary cirrhosis.","volume":"106","author":"Lindor","year":"1994","journal-title":"Gastroenterology"},{"key":"R6-20-20210305","first-page":"759","article-title":"A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis.","volume":"22","author":"Combes","year":"1995","journal-title":"Hepatology"},{"key":"R7-20-20210305","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0168-8278(00)80216-0","article-title":"Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver.","volume":"32","author":"Pares","year":"2000","journal-title":"J Hepatol"},{"key":"R8-20-20210305","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4065\/72.12.1137","article-title":"Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis.","volume":"72","author":"Lindor","year":"1997","journal-title":"Mayo Clin Proc"},{"key":"R9-20-20210305","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/hep.510290301","article-title":"Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis.","volume":"29","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"key":"R10-20-20210305","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0016-5085(97)70183-5","article-title":"Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis.","volume":"113","author":"Poupon","year":"1997","journal-title":"Gastroenterology"},{"key":"R11-20-20210305","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/0016-5085(89)90526-X","article-title":"Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history, and influence on survival.","volume":"96","author":"Gores","year":"1989","journal-title":"Gastroenterology"},{"key":"R12-20-20210305","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/hep.21907","article-title":"Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis.","volume":"46","author":"Garcia-Tsao","year":"2007","journal-title":"Hepatology"},{"key":"R13-20-20210305","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(69)92595-1","article-title":"Bleeding oesophageal varices as the presenting feature in primary biliary cirrhosis.","volume":"2","author":"Zeegen","year":"1969","journal-title":"Lancet"},{"key":"R14-20-20210305","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gut.12.10.830","article-title":"Portal hypertension in primary biliary cirrhosis.","volume":"12","author":"Kew","year":"1971","journal-title":"Gut"},{"key":"R15-20-20210305","first-page":"8","article-title":"Nodular hyperplasia of the liver in primary biliary cirrhosis of early histological stages.","volume":"82","author":"Nakanuma","year":"1987","journal-title":"Am J Gastroenterol"},{"key":"R16-20-20210305","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0168-8278(87)80035-1","article-title":"Portal hypertension in primary biliary cirrhosis. Relationship with histological features.","volume":"5","author":"Navasa","year":"1987","journal-title":"J Hepatol"},{"key":"R17-20-20210305","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0016-5085(92)90771-P","article-title":"Nodular regenerative hyperplasia of the liver in early histological stages of primary biliary cirrhosis.","volume":"102","author":"Colina","year":"1992","journal-title":"Gastroenterology"},{"key":"R18-20-20210305","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.21472","article-title":"Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis.","volume":"45","author":"Nakamura","year":"2007","journal-title":"Hepatology"},{"key":"R19-20-20210305","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1007\/s00535-006-1914-y","article-title":"Clinical features of symptomatic primary biliary cirrhosis initially complicated with esophageal varices.","volume":"41","author":"Murata","year":"2006","journal-title":"J Gastroenterol"},{"key":"R20-20-20210305","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0168-8278(99)80136-6","article-title":"Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial.","volume":"30","author":"Angulo","year":"1999","journal-title":"J Hepatol"},{"key":"R21-20-20210305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840100102","article-title":"Prognosis in primary biliary cirrhosis: model for decision making.","volume":"10","author":"Dickson","year":"1989","journal-title":"Hepatology"},{"key":"R22-20-20210305","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00432479","article-title":"Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis).","volume":"379","author":"Ludwig","year":"1978","journal-title":"Virchows Arch"},{"key":"R23-20-20210305","first-page":"405","article-title":"Histological and histometric examination of the intrahepatic portal vein branches in primary biliary cirrhosis without regenerative nodules.","volume":"77","author":"Nakanuma","year":"1982","journal-title":"Am J Gastroenterol"},{"key":"R24-20-20210305","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis.","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"R25-20-20210305","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.cgh.2007.02.031","article-title":"Prevalence and predictors of esophageal varices in patients with primary biliary cirrhosis.","volume":"5","author":"Levy","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R26-20-20210305","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1478-3231.1999.tb00020.x","article-title":"Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid.","volume":"19","author":"Angulo","year":"1999","journal-title":"Liver"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCG.0b013e3181f18c4e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:08:37Z","timestamp":1620961717000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004836-201108000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0b013e3181f18c4e","relation":{},"ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}